Voyageur Pharmaceuticals (VYYRF) News Today $0.15 +0.02 (+19.05%) As of 01/28/2025 12:46 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Voyageur Pharmaceuticals exercises warrants to secure additional capitalJanuary 24, 2025 | proactiveinvestors.comVoyageur Pharmaceuticals reflects on pivotal 2024 with product launches and strategic alliancesJanuary 15, 2025 | proactiveinvestors.comVoyageur Pharmaceuticals With CEO, Brent Willis | January 14th, 2025January 14, 2025 | msn.comVoyageur Commences Testing of Innovative Barium Contrast Product Line in Human Radiology Scans, Paving the Way for Near-Term Market LaunchJanuary 13, 2025 | finance.yahoo.comVoyageur Pharmaceuticals begins human testing of barium contrast productsJanuary 13, 2025 | proactiveinvestors.comVoyageur Pharmaceuticals: Major partnership fuels 2025 plans – ICYMIJanuary 10, 2025 | proactiveinvestors.comVoyageur Pharmaceuticals Expands Market with Strategic CollaborationDecember 20, 2024 | tipranks.comVoyageur Pharmaceuticals strikes partnership to accelerate contrast media productionDecember 20, 2024 | proactiveinvestors.comVoyageur Pharmaceuticals completes final tranche of private placementDecember 19, 2024 | proactiveinvestors.comVoyageur Announces Closing of Final Tranche of Private PlacementDecember 18, 2024 | finance.yahoo.comVoyageur Pharmaceuticals completes first tranche of private placementDecember 4, 2024 | proactiveinvestors.comVoyageur Pharmaceuticals Extends Private Placement TimelineNovember 26, 2024 | tipranks.comVoyageur Pharmaceuticals launches C$1M private placementOctober 17, 2024 | proactiveinvestors.comVoyageur Pharmaceuticals adds new vice president of business developmentSeptember 24, 2024 | proactiveinvestors.comVoyageur Pharmaceuticals welcomes new chief science officerSeptember 17, 2024 | proactiveinvestors.comVoyageur Pharmaceuticals completes formulation of innovative diagnostic products, eyes FDA approvalSeptember 5, 2024 | proactiveinvestors.comVoyageur Introduces Five New Barium Contrast Formulations Setting New Standards in Medical Imaging IndustrySeptember 5, 2024 | stockhouse.comVoyageur Pharmaceuticals CEO shares major progress in MRI drug innovation with Rain CageJune 12, 2024 | proactiveinvestors.comVoyageur Pharmaceuticals announces new collaboration with Rain Cage CarbonJune 11, 2024 | proactiveinvestors.comVoyageur Pharmaceuticals partner Rain Cage Carbon and Toyota Tsusho Canada forge alliance for sustainable automotive solutionsJune 6, 2024 | proactiveinvestors.comVoyageur Pharmaceuticals wins US$1.9M sales contract for SmoothX 2% barium contrast productMay 28, 2024 | proactiveinvestors.comVoyageur Pharmaceuticals Ltd Signs Radiology Drug Sales Contract Valued at $USD 1.9 Million for SmoothX 2% Barium ContrastMay 27, 2024 | finance.yahoo.comVoyageur Pharmaceuticals poised to shake up medical imaging market with API partnershipMarch 5, 2024 | proactiveinvestors.comVoyageur Pharmaceuticals to fast-track commercialization of imaging contrast agents through API partnershipMarch 4, 2024 | proactiveinvestors.comVoyageur Pharmaceuticals "sees a gap in the market" for domestically-produced bariumSeptember 28, 2023 | finance.yahoo.comVoyageur Pharmaceuticals GAAP EPS of -$0.51, revenue of $4.85MAugust 3, 2023 | msn.comVoyageur Pharmaceuticals with a "big market to go for"June 6, 2023 | proactiveinvestors.comVoyageur Pharmaceuticals partners with Rain Cage to develop nanocarbon-based radiology drugsMay 26, 2023 | proactiveinvestors.comThe Power Play by The Market Herald Releases New Interviews with Solar Alliance, Cleantek Industries, Voyageur Pharmaceuticals and Homerun Resources Discussing Their Latest NewsMay 24, 2023 | finance.yahoo.comVoyageur Pharmaceuticals' SmoothX abdominal diagnostic drink gets high praise in comparative studyApril 13, 2023 | finance.yahoo.comThe Power Play by The Market Herald Releases New Interviews with Luminex Resources, Voyageur Pharmaceuticals, Trillion Energy, ARway and Pan Global Resources Discussing Their Latest NewsApril 11, 2023 | finance.yahoo.comVoyageur Pharmaceuticals is pursing an innovative 'earth to bottle' model through its ownership of natural barium and iodine resourcesJanuary 23, 2023 | proactiveinvestors.comVoyageur Pharmaceuticals increases maximum size of its non-brokered private placement to $1.2M due to strong investor demandJanuary 13, 2023 | proactiveinvestors.comThe Power Play by The Market Herald Releases New Interviews with Trillion, Gamelancer, INEO Tech, ACME Lithium and Voyageur Discussing Their Latest NewsNovember 30, 2022 | finance.yahoo.comInvestmentPitch Media Video Discusses Voyageur Pharmaceuticals’ Completed Production of a Test Batch of its SmoothX™ Barium Sulfate CT Contrast Media Oral Suspension for the Canadian CT Imaging MarketNovember 29, 2022 | finance.yahoo.comVoyageur Pharmaceuticals completes production testing of SmoothX; begins scale-up for Canadian imaging marketNovember 28, 2022 | proactiveinvestors.comVoyageur Pharmaceuticals Ltd. Completes Medical Imaging CT Contrast Agent Production Testing and Begins Production Scale-up of SmoothX(TM)November 28, 2022 | finance.yahoo.comInvestmentPitch Media Video Discusses Voyageur Pharmaceuticals’ Completion of the design of its Carbon Neutral Pharmaceutical Facility and Accelerated Revenue Generation Timeline for its Frances Creek Barium Sulfate ProjectNovember 1, 2022 | finance.yahoo.comVoyageur Pharmaceuticals accelerates revenue generation timeline for Frances Creek barium sulphate projectOctober 31, 2022 | proactiveinvestors.comInvestmentPitch Media Video Discusses Voyageur Pharmaceuticals’ MOU with Rain Cage Carbon to Develop Fullerene-Based Medical Contrast Agents from Carbon Capture of Hydrocarbon Exhaust SystemsOctober 26, 2022 | finance.yahoo.comVoyageur Pharmaceuticals says Rain Cage Carbon deal will make it a carbon neutral manufacturerOctober 25, 2022 | proactiveinvestors.comVoyageur Pharmaceuticals signs MOU to develop fullerene contrast agents for medical imaging applications and carbon capture technologyOctober 24, 2022 | proactiveinvestors.comVoyageur Pharmaceuticals in the right space at the right time with its 'earth-to-bottle' modelOctober 12, 2022 | proactiveinvestors.comInvestmentPitch Media Video Discusses Voyageur Pharmaceuticals’ Notice of Work with the BC Ministry of Mines, for the Removal of 2,000 Tonnes of Barium Sulfate from its Frances Creek ProjectSeptember 23, 2022 | finance.yahoo.comVoyageur Mineral Explorers Corp. Options North Star - Gold Rock ProjectJune 16, 2022 | finance.yahoo.comVoyageur Pharmaceuticals Ltd. Announces Proposed Private PlacementMay 26, 2022 | stockhouse.comVoyageur Pharmaceuticals Announces Publication of the Jubilee Mountain NI 43-101 Report & Staking of Falcon Claims- Copper Polymetallic AssetsFebruary 16, 2022 | stockhouse.comInvestmentPitch Media Video Discusses Voyageur Pharmaceuticals' PEA with NPV of $344 million and 137% IRR for Frances Creek Pharmaceutical Barium Project in BC - Video Available on Investmentpitch.comJanuary 13, 2022 | finance.yahoo.comIIROC Trading Halt - VMJanuary 11, 2022 | finance.yahoo.comIIROC Trading Resumption - VMJanuary 11, 2022 | finance.yahoo.com Get Voyageur Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VYYRF and its competitors with MarketBeat's FREE daily newsletter. Email Address VYYRF Media Mentions By Week VYYRF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VYYRF News Sentiment▼1.000.72▲Average Medical News Sentiment VYYRF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VYYRF Articles This Week▼10▲VYYRF Articles Average Week Get Voyageur Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VYYRF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TGIFF News Today FFNTF News Today ABSCF News Today ACRHF News Today LBTSF News Today AZFL News Today ERBB News Today AVTBF News Today AVCNF News Today BIOYF News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:VYYRF) was last updated on 1/31/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMan Who Called Nvidia Says: “Your Retirement Is Inside This Building.”In 2016, Jeff Brown called Nvidia at a split-adjusted 66 cents. The company just became the world's third $...Brownstone Research | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Voyageur Pharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Voyageur Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
